Natixis Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.9M | Buy |
|
|||||
|
2025
Q1 | $72M | Buy |
|
|||||
|
2024
Q4 | $45.5M | Sell |
|
|||||
|
2024
Q3 | $99.9M | Buy |
|
|||||
|
2024
Q2 | $96.2M | Buy |
|
|||||
|
2024
Q1 | $89.2M | Buy |
|
|||||
|
2023
Q4 | $75.8M | Buy |
|
|||||
|
2023
Q3 | $62.2M | Buy |
|
|||||
|
2023
Q2 | $58.6M | Sell |
|
|||||
|
2023
Q1 | $75.1M | Sell |
|
|||||
|
2022
Q4 | $85.8M | Sell |
|
|||||
|
2022
Q3 | $84.6M | Buy |
|
|||||
|
2022
Q2 | $85.4M | Buy |
|
|||||
|
2022
Q1 | $86.2M | Buy |
|
|||||
|
2021
Q4 | $77M | Buy |
|
|||||
|
2021
Q3 | $58.5M | Sell |
|
|||||
|
2021
Q2 | $60.2M | Buy |
|
|||||
|
2021
Q1 | $54.5M | Buy |
|
|||||
|
2020
Q4 | $47.2M | Buy |
|
|||||
|
2020
Q3 | $37.6M | Buy |
|
|||||
|
2020
Q2 | $36.7M | Buy |
|
|||||
|
2020
Q1 | $28.8M | Buy |
|
|||||
|
2019
Q4 | $33.8M | Buy |
|
|||||
|
2019
Q3 | $23.3M | Sell |
|
|||||
|
2019
Q2 | $32.6M | Buy |
|
|||||
|
2019
Q1 | $28.2M | Sell |
|
|||||
|
2018
Q4 | $27.3M | Buy |
|
|||||
|
2018
Q3 | $27.7M | Sell |
|
|||||
|
2018
Q2 | $27.6M | Buy |
|
|||||
|
2018
Q1 | $25M | Buy |
|
|||||
|
2017
Q4 | $25.2M | Sell |
|
|||||
|
2017
Q3 | $21.7M | Sell |
|
|||||
|
2017
Q2 | $21.7M | Sell |
|
|||||
|
2017
Q1 | $26.9M | Sell |
|
|||||
|
2016
Q4 | $24.3M | Buy |
|
|||||
|
2016
Q3 | $21M | Sell |
|
|||||
|
2016
Q2 | $22.2M | Buy |
|
|||||
|
2016
Q1 | $21.8M | Buy |
|
|||||
|
2015
Q4 | $7.66M | Buy |
|
|||||
|
2015
Q3 | $7.18M | Sell |
|
|||||
|
2015
Q2 | $9.29M | Sell |
|
|||||
|
2015
Q1 | $9.11M | Buy |
|
|||||
|
2014
Q4 | $4.89M | Sell |
|
|||||
|
2014
Q3 | $5.03M | Buy |
|
|||||
|
2014
Q2 | $3.43M | Buy |
|
|||||
|
2014
Q1 | $2.71M | Sell |
|
|||||
|
2013
Q4 | $2.58M | Buy |
|
|||||
|
2013
Q3 | $2.12M | Sell |
|
|||||
|
2013
Q2 | $2.57M | Buy |
|